Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Uniqure NV (NASDAQ:QURE)

5.81
Delayed Data
As of 3:59pm ET
 +0.13 / +2.29%
Today’s Change
5.25
Today|||52-Week Range
15.00
+3.75%
Year-to-Date
No recent news for Uniqure NV.

Today’s Trading

Previous close5.68
Today’s open5.81
Day’s range5.63 - 5.84
Volume118,734
Average volume (3 months)237,566
Market cap$144.5M
Dividend yield--
Data as of 3:59pm ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)-25.40%
Earnings growth (this year)+16.78%
Earnings growth (next 5 years)-26.60%
Revenue growth (last year)+68.18%
P/E ratio--
Price/Sales34.95
Price/Book1.06

Competitors

 Today’s
change
Today’s
% change
PLXProtalix Biotherapeu...-0.02-1.75%
VBLTVascular Biogenics L...+0.10+1.80%
ASTAsterias Biotherapeu...0.000.00%
EVGNEvogene Ltd+0.04+0.77%
Data as of 4:00pm ET, 03/24/2017

Financials

Next reporting dateJune 15, 2017
EPS forecast (this quarter)-$0.68
Annual revenue (last year)$10.5M
Annual profit (last year)-$79.3M
Net profit margin-758.41%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer, CFO &
Executive Director
Matt Kapusta
Chief Operating Officer
Eric Goossens
Corporate headquarters
Amsterdam, Noord-holland

Forecasts


Search for Jobs